Meeting report Considerations for trial design and endpoints in licensing therapeutic HPV1618 vaccines to prevent cervical cancer

Simple item page
dc.article.end-page9en
dc.article.start-page1en
dc.citation.doi10.1016/J.VACCINE.2024.07.001en
dc.contributor.authorPeter M Dullen
dc.contributor.authorSharon L Achillesen
dc.contributor.authorRafi Ahmeden
dc.contributor.authorRuanne V Barnabasen
dc.contributor.authorE et alen
dc.contributor.authorPaul Ruffen
dc.date.accessioned2024-11-19T10:07:27Z
dc.date.available2024-11-19T10:07:27Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0264-410Xen
dc.identifier.urihttps://hdl.handle.net/10539/42728
dc.journal.titleMeeting report Considerations for trial design and endpoints in licensing therapeutic HPV1618 vaccines to prevent cervical canceren
dc.journal.volume42en
dc.school1.02en
dc.titleMeeting report Considerations for trial design and endpoints in licensing therapeutic HPV1618 vaccines to prevent cervical canceren
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
714.3 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)